|Professor. Yitao Wang (王一濤 教授)|
Director of the State Key Laboratory of Quality Research in Chinese Medicine (University of Macau)
Prof. Yitao Wang is currently Chair Professor, and Director of the State Key Laboratory of Quality Research in Chinese Medicine (SKL-QRCM), at University of Macau (UM).
Prof. Wang was Director of Institute of Chinese Medical Sciences (ICMS), Director of Institute of Chinese Materia Medica, and Vice President of China Academy of Chinese Medical Sciencesi n 1996, where he became the Chief Scientist in 1999. He was appointed as Professor and Director for the CM Programme at Hong Kong University of Science and Technology (HKUST) in 2000-2002. In 2002, he was invited to join UM to initiate ICMS as the founding director, and he subsequently founded SKL-QRCM as the founding director. He was appointed as Chair Professor at UM in 2013.
Prof. Wang has devoted himself into the medicinal education and Chinese Medicine (CM) studies. He founded the first national key discipline in CM, the first national talents programme in CM. He was also the Chief Scientist for the first National Basic Research Program of China (973 Program) in TCM, and initiated and led the foundation of the first SKL in TCM in China.
He has supervised more than 100 PhD and MSc students, published 446 SCI papers with a total citation of 19298 times and h-index of 71，and edited 16 books in CM and has 16 patents. He became the National Council Special Allowance Expert in 1992, and won numerous awards including Macau Medal of Merit-Education (2011), National Science and Technology Progress Award (2016), Macao Science and Technology Awards-Special Award (2018), the 5th Cheung On Tak International Award for Outstanding Contribution to Chinese Medicine (2020), and eight other prestigious awards issued by Macao SAR governments and Ministries of China.
In 2020, Prof. Wang has been appointed as the Deputy Team Leader of CM Prescriptions Screening of the Joint Prevention and Control Panel of the State Council, and a member of the Coordination Group for Promotion of the Chinese Medicine Industry of the Macao SAR Government. He has also been a member of the Macao SAR Economic Development Committee, Science and Technology Committee and Medical Affairs Committee, as well as in several national committee including National Science and Technology Programmes, the State Science and Technology Awards, National Natural Science Foundation, and NMPA Centre for Drug Evaluation. He is also General Secretory for the International Society for Chinese Medicine, Chairman of International Society of Quality Research in Chinese Medicine, executive member of the Presidium of the World Federation of Chinese Medicine Societies, and Editor-in-Chief of a SCI journal “Chinese Medicine” (ranked the first in Impact Factor among all TCM journals in greater China region).